Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke.

作者: Ping Zhuang , Da Wo , Zeng-guang Xu , Wei Wei , Hui-ming Mao

DOI: 10.1016/J.JOCN.2014.12.027

关键词:

摘要: The aim of this paper is to investigate the corresponding variations plasma tissue plasminogen activator (t-PA) and inhibitor-1 (PAI-1) activities, beta-thromboglobulin (β-TG) content in patients during different stages ischemic stroke. Ischemic stroke a common disease among aging people its occurrence associated with abnormalities fibrinolytic system platelet function. However, few reports focus on dynamic changes β-TG Patients were divided into three groups: acute, convalescent chronic. Plasma t-PA PAI-1 activities determined by chromogenic substrate analysis was detected radioimmunoassay. acute stage had significantly increased levels activity content, but decreased. Negative correlations found between There significant differences aged control group, as well chronic groups. It can be speculated that result compensatory function, increase level not only implies presence likely cause During later stroke, greater attention required monitoring PAI-1.

参考文章(25)
Beşirli K, Ekmekçi H, Atukeren P, Ekmekçi Ob, Sönmez H, Işler Bütün I, Güngör Öztürk Z, Gode S, Significance of vitronectin and PAI-1 activity levels in carotid artery disease: comparison of symptomatic and asymptomatic patients. Minerva Medica. ,vol. 104, pp. 215- ,(2013)
Olivier Nicole, Fabian Docagne, Carine Ali, Isabelle Margaill, Peter Carmeliet, Eric T. MacKenzie, Denis Vivien, Alain Buisson, The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nature Medicine. ,vol. 7, pp. 59- 64 ,(2001) , 10.1038/83358
Takeshi Soeki, Yoshiyuki Tamura, Nobuo Fukuda, Susumu Ito, Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction. Japanese Circulation Journal-english Edition. ,vol. 64, pp. 547- 553 ,(2000) , 10.1253/JCJ.64.547
J. Montaner, Stroke biomarkers: Can they help us to guide stroke thrombolysis? Drug News & Perspectives. ,vol. 19, pp. 523- ,(2006) , 10.1358/DNP.2006.19.9.1050422
Simon Jung, Christian Stapf, Marcel Arnold, Stroke unit management and revascularisation in acute ischemic stroke. European Neurology. ,vol. 73, pp. 98- 105 ,(2015) , 10.1159/000365210
Naohisa Hosomi, Jacinta Lucero, Ji Hoe Heo, James A. Koziol, Brian R. Copeland, Gregory J. del Zoppo, Rapid Differential Endogenous Plasminogen Activator Expression After Acute Middle Cerebral Artery Occlusion Stroke. ,vol. 32, pp. 1341- 1348 ,(2001) , 10.1161/01.STR.32.6.1341
Biljana Vuckovic, Mirjana Djeric, Marija Zarkov, Influence of fibrinolitic potential reduction in ischemic brain disease development Medicinski Pregled. ,vol. 61, pp. 247- 251 ,(2008) , 10.2298/MPNS0806247V
Resmi Ravindran, Lissy K. Krishnan, A Biochemical Study on the Effect of Proteolysis of Beta-Thromboglobulin Proteins Released from Activated Platelets on Fibroblast Proliferation Pathophysiology of Haemostasis and Thrombosis. ,vol. 36, pp. 285- 289 ,(2007) , 10.1159/000296282
Kazuomi Kario, Yuichirou Yano, Takefumi Matsuo, Satoshi Hoshide, Kazuo Eguchi, Kazuyuki Shimada, Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients. European Heart Journal. ,vol. 32, pp. 574- 580 ,(2011) , 10.1093/EURHEARTJ/EHQ444